Erasca (ERAS) Capital Expenditures (2020 - 2026)
Erasca (ERAS) reported Capital Expenditures of $36000.0 for Q1 2026, down 56.63% on a YoY basis from $83000.0 in Q1 2025, and up 300.0% quarter-over-quarter from $9000.0 in Q4 2025.
Erasca (ERAS) Capital Expenditures (2020 - 2026) Analysis & Trends
Erasca has reported Capital Expenditures for 7 years, with the latest figure at $36000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures fell 56.63% year-over-year to $36000.0; the trailing twelve-month figure through Mar 2026 stood at $81000.0 (down 19.8% YoY), and the FY2025 full-year result was $128000.0, up 113.33% from the prior year.
- Capital Expenditures for Q1 2026 stood at $36000.0, up from $9000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $7.3 million in Q1 2022, with the low at $5000.0 in Q3 2024.
- Historically, Capital Expenditures has averaged $1.0 million across 5 years, with a median of $82500.0 in 2023.
- Annual changes were most pronounced in 2022 — Capital Expenditures surged 5913.11% — and 2024, when it tumbled 97.92%.
- Erasca's Capital Expenditures stood at $864000.0 in 2022, then slumped by 90.51% to $82000.0 in 2023, then sank by 93.9% to $5000.0 in 2024, then soared by 80.0% to $9000.0 in 2025, then jumped by 300.0% to $36000.0 in 2026.
- The last three Capital Expenditures figures came in at $36000.0 (Q1 2026), $9000.0 (Q4 2025), and $6000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Erasca | 4.16 Bn | 3.92 Bn | - | 36,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36,000.00 |
| Mar 31, 2026 | 36,000.00 |
| Dec 31, 2025 | 9,000.00 |
| Dec 31, 2025 | 9,000.00 |
| Sep 30, 2025 | 6,000.00 |
| Sep 30, 2025 | 6,000.00 |
| Jun 30, 2025 | 30,000.00 |
| Jun 30, 2025 | 30,000.00 |
| Mar 31, 2025 | 83,000.00 |
| Mar 31, 2025 | 83,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Jun 30, 2024 | 13,000.00 |
| Jun 30, 2024 | 13,000.00 |
| Mar 31, 2024 | 42,000.00 |
| Mar 31, 2024 | 42,000.00 |
| Dec 31, 2023 | 82,000.00 |
| Dec 31, 2023 | 82,000.00 |
| Sep 30, 2023 | 240,000.00 |
| Sep 30, 2023 | 240,000.00 |